Literature DB >> 10919901

Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome.

J Shimazaki1, S Shimmura, H Fujishima, K Tsubota.   

Abstract

OBJECTIVE: To retrospectively study the surgical outcome in severe Stevens-Johnson syndrome (SJS).
DESIGN: Retrospective noncomparative case series. PARTICIPANTS: Twenty-nine eyes of patients with severe SJS associated with total conjunctivalization were examined. INTERVENTION: Preserved human amniotic membrane grafting and keratolimbal allograft transplantation was performed. Intensive immunosuppression and epithelial management were continued postoperatively. MAIN OUTCOME MEASURES: Successful ocular surface reconstruction was determined by epithelialization with corneal epithelium. The association between surgical outcome and preoperative tear function was studied.
RESULTS: The ocular surface was successfully covered by corneal epithelium in 13 eyes (44.8%). The mean corrected visual acuity recovered from 0.0039 to 0.017. Persistent epithelial defect was the most common complication. Eyes with successful ocular surface reconstruction had significantly better preoperative Schirmer's test values (P = 0.025) and tear clearance rates (P = 0.043) than those that failed.
CONCLUSIONS: In patients with severe SJS, preoperative tear function significantly influenced surgical outcome. Eyes with Schirmer's test value of >10 mm have a greater chance of successful ocular surface reconstruction.

Entities:  

Mesh:

Year:  2000        PMID: 10919901     DOI: 10.1016/s0161-6420(00)00214-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders.

Authors:  T Nakamura; T Inatomi; C Sotozono; T Amemiya; N Kanamura; S Kinoshita
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

2.  Limbal stem cell disease: Treatment and advances in technology.

Authors:  Hall F Chew
Journal:  Saudi J Ophthalmol       Date:  2011-05-24

3.  Development of a cell sheet transportation technique for regenerative medicine.

Authors:  Yoshinori Oie; Takayuki Nozaki; Hiroshi Takayanagi; Susumu Hara; Ryuhei Hayashi; Shizu Takeda; Keisuke Mori; Noboru Moriya; Takeshi Soma; Motokazu Tsujikawa; Kazuo Saito; Kohji Nishida
Journal:  Tissue Eng Part C Methods       Date:  2013-11-26       Impact factor: 3.056

Review 4.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

5.  Long-term outcome and prognostic factor analysis for keratolimbal allografts.

Authors:  Eui Seok Han; Won Ryang Wee; Jin Hak Lee; Mee Kum Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-12       Impact factor: 3.117

6.  Long-term follow-up of transplantation of preserved limbal allograft and amniotic membrane for recurrent pterygium.

Authors:  Takashi Ono; Yosai Mori; Ryohei Nejima; Tadatoshi Tokunaga; Kazunori Miyata; Shiro Amano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-26       Impact factor: 3.117

7.  The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.

Authors:  M Victoria De Rojas; John K G Dart; Valerie P J Saw
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

8.  Update on limbal stem cell transplantation.

Authors:  Pejman Bakhtiari; Ali Djalilian
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

Review 9.  Limbal stem cell transplantation: new progresses and challenges.

Authors:  L Liang; H Sheha; J Li; S C G Tseng
Journal:  Eye (Lond)       Date:  2008-12-19       Impact factor: 3.775

10.  Autologous transplantation of conjunctival epithelial cells cultured on amniotic membrane in a rabbit model.

Authors:  Kyoko Ono; Seiichi Yokoo; Tatsuya Mimura; Tomohiko Usui; Kazunori Miyata; Makoto Araie; Satoru Yamagami; Shiro Amano
Journal:  Mol Vis       Date:  2007-07-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.